09/26/2022
Dr. Nicholas Vogelzang, renowned medical oncologist and cancer researcher specializing in genitourinary cancers, dies at 72.
The Prostate Cancer Foundation (PCF) is sad to share news of the recent passing of a giant in the field of genitourinary (GU) medical oncology, Dr. Nicholas J. Vogelzang. Dr. Vogelzang (or Nick, as many of his colleagues knew him) dedicated his professional life to researching and treating rare forms. Read More
07/11/2022
Meet Chuck Ryan, M.D.
“I don’t think we’ve ever been in a more exciting time in prostate cancer and oncology, with advances in targeted therapies, hormonal therapies, cellular therapies, radioligand therapies. We don’t know what’s the next big thing, but we know that all of those approaches can be refined even further. We’ve got. Read More
11/08/2011
PCF submits comments to USPSTF regarding PSA-based screening
November 8, 2011 Robert Cosby, Ph.D. Senior Coordinator U.S. Preventive Services Task Force 540 Gaither Road Rockville, MD 20850 Re: OPPORTUNITY FOR PUBLIC COMMENT– SCREENING FOR PROSTATE CANCER–USPSTF RECOMMENDATION STATEMENT DRAFT Dear Dr. Cosby: This letter is to provide comments in response to the U.S. Preventive Services Task Force’s (USPSTF). Read More